124 related articles for article (PubMed ID: 22862148)
1. Discovery and optimization of 1,3,4-trisubstituted-pyrazolone derivatives as novel, potent, and nonsteroidal farnesoid X receptor (FXR) selective antagonists.
Huang H; Yu Y; Gao Z; Zhang Y; Li C; Xu X; Jin H; Yan W; Ma R; Zhu J; Shen X; Jiang H; Chen L; Li J
J Med Chem; 2012 Aug; 55(16):7037-53. PubMed ID: 22862148
[TBL] [Abstract][Full Text] [Related]
2. Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of Farnesoid X Receptor (FXR) agonists.
Marinozzi M; Carotti A; Sansone E; Macchiarulo A; Rosatelli E; Sardella R; Natalini B; Rizzo G; Adorini L; Passeri D; De Franco F; Pruzanski M; Pellicciari R
Bioorg Med Chem; 2012 Jun; 20(11):3429-45. PubMed ID: 22564381
[TBL] [Abstract][Full Text] [Related]
3. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
4. Identification of trisubstituted-pyrazol carboxamide analogs as novel and potent antagonists of farnesoid X receptor.
Yu DD; Lin W; Forman BM; Chen T
Bioorg Med Chem; 2014 Jun; 22(11):2919-38. PubMed ID: 24775917
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of Novel Nonsteroidal Farnesoid X Receptor (FXR) Antagonists: Molecular Basis of FXR Antagonism.
Huang H; Si P; Wang L; Xu Y; Xu X; Zhu J; Jiang H; Li W; Chen L; Li J
ChemMedChem; 2015 Jul; 10(7):1184-99. PubMed ID: 25982493
[TBL] [Abstract][Full Text] [Related]
6. Identification of a lead pharmacophore for the development of potent nuclear receptor modulators as anticancer and X syndrome disease therapeutic agents.
Lin HR; Abraham DJ
Bioorg Med Chem Lett; 2006 Aug; 16(16):4178-83. PubMed ID: 16784849
[TBL] [Abstract][Full Text] [Related]
7. Identification of farnesoid X receptor modulators by a fluorescence polarization-based interaction assay.
Han KC; Kim JH; Kim KH; Kim EE; Seo JH; Yang EG
Anal Biochem; 2010 Mar; 398(2):185-90. PubMed ID: 19913492
[TBL] [Abstract][Full Text] [Related]
8. Improvement of physiochemical properties of the tetrahydroazepinoindole series of farnesoid X receptor (FXR) agonists: beneficial modulation of lipids in primates.
Lundquist JT; Harnish DC; Kim CY; Mehlmann JF; Unwalla RJ; Phipps KM; Crawley ML; Commons T; Green DM; Xu W; Hum WT; Eta JE; Feingold I; Patel V; Evans MJ; Lai K; Borges-Marcucci L; Mahaney PE; Wrobel JE
J Med Chem; 2010 Feb; 53(4):1774-87. PubMed ID: 20095622
[TBL] [Abstract][Full Text] [Related]
9. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
Evans MJ; Mahaney PE; Borges-Marcucci L; Lai K; Wang S; Krueger JA; Gardell SJ; Huard C; Martinez R; Vlasuk GP; Harnish DC
Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G543-52. PubMed ID: 19136377
[TBL] [Abstract][Full Text] [Related]
10. 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity.
Pellicciari R; Fiorucci S; Camaioni E; Clerici C; Costantino G; Maloney PR; Morelli A; Parks DJ; Willson TM
J Med Chem; 2002 Aug; 45(17):3569-72. PubMed ID: 12166927
[TBL] [Abstract][Full Text] [Related]
11. Pyrazolidine-3,5-dione derivatives as potent non-steroidal agonists of farnesoid X receptor: virtual screening, synthesis, and biological evaluation.
Deng G; Li W; Shen J; Jiang H; Chen K; Liu H
Bioorg Med Chem Lett; 2008 Oct; 18(20):5497-502. PubMed ID: 18815030
[TBL] [Abstract][Full Text] [Related]
12. Discovery of sulfated sterols from marine invertebrates as a new class of marine natural antagonists of farnesoid-X-receptor.
Sepe V; Bifulco G; Renga B; D'Amore C; Fiorucci S; Zampella A
J Med Chem; 2011 Mar; 54(5):1314-20. PubMed ID: 21309576
[TBL] [Abstract][Full Text] [Related]
13. [Progress in the ligands and their complex structures of farnesoid X receptor].
Li WH; Fu J; Zheng MY; Liu GX; Tang Y
Yao Xue Xue Bao; 2012 Jun; 47(6):704-15. PubMed ID: 22919716
[TBL] [Abstract][Full Text] [Related]
14. The farnesoid X receptor induces very low density lipoprotein receptor gene expression.
Sirvent A; Claudel T; Martin G; Brozek J; Kosykh V; Darteil R; Hum DW; Fruchart JC; Staels B
FEBS Lett; 2004 May; 566(1-3):173-7. PubMed ID: 15147890
[TBL] [Abstract][Full Text] [Related]
15. Activation of farnesoid X receptor increases the expression of cytokine inducible SH2-containing protein in HepG2 cells.
Xu Z; Huang G; Gong W; Zhao Y; Zhou P; Zeng Y; He F
J Interferon Cytokine Res; 2012 Nov; 32(11):517-23. PubMed ID: 22817871
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist.
Kainuma M; Makishima M; Hashimoto Y; Miyachi H
Bioorg Med Chem; 2007 Apr; 15(7):2587-600. PubMed ID: 17292610
[TBL] [Abstract][Full Text] [Related]
17. Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase.
Shen LL; Liu H; Peng J; Gan L; Lu L; Zhang Q; Li L; He F; Jiang Y
Mol Biol Rep; 2011 Jan; 38(1):553-9. PubMed ID: 20373033
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of novel class II c-Met inhibitors: 2. SAR and kinase selectivity profiles of the pyrazolone series.
Liu L; Norman MH; Lee M; Xi N; Siegmund A; Boezio AA; Booker S; Choquette D; D'Angelo ND; Germain J; Yang K; Yang Y; Zhang Y; Bellon SF; Whittington DA; Harmange JC; Dominguez C; Kim TS; Dussault I
J Med Chem; 2012 Mar; 55(5):1868-97. PubMed ID: 22320327
[TBL] [Abstract][Full Text] [Related]
19. Binding mechanism of the farnesoid X receptor marine antagonist suvanine reveals a strategy to forestall drug modulation on nuclear receptors. Design, synthesis, and biological evaluation of novel ligands.
Di Leva FS; Festa C; D'Amore C; De Marino S; Renga B; D'Auria MV; Novellino E; Limongelli V; Zampella A; Fiorucci S
J Med Chem; 2013 Jun; 56(11):4701-17. PubMed ID: 23656455
[TBL] [Abstract][Full Text] [Related]
20. Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor.
Campana G; Pasini P; Roda A; Spampinato S
Biochem Pharmacol; 2005 Jun; 69(12):1755-63. PubMed ID: 15935148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
